Search results
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Motley Fool via Yahoo Finance· 6 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
How do Cleveland-area hospitals rate on Leapfrog’s new patient safety grade report?
The Cleveland Plain Dealer· 24 hours agoSafety ratings mixed among Greater Cleveland hospitals in Leapfrog's updated grades
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $50.80 Average Target Price from Brokerages
ETF DAILY NEWS· 8 hours agoFree Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the stock, MarketBeat.com reports. The average 1 year target price ...
The rise and fall of Red Lobster, whose bottomless shrimp may be leading to bankruptcy
INSIDER via Yahoo News· 22 hours agoServers were also reportedly instructed to cover 10 tables per service instead of three in an effort...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
CNN Business via AOL· 3 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 21 hours agoThe paper’s purpose was to inform the ministers about the discussions at the latest UK-wide Cobra...
India’s Lower Voter Turnout Raises Questions of BJP Fatigue
Bloomberg via Yahoo News· 1 day ago(Bloomberg) -- Sign up for the India Edition newsletter by Menaka Doshi – an insider's guide to the...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 1 day ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Meghan Markle Details Sweet Moment With Her & Prince Harry’s Daughter
E! News via Yahoo News· 23 hours agoDuring Meghan Markle and Prince Harry’s first international visit since stepping down from their...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator....